State Of Tennessee, Treasury Department Biogen Inc. Transaction History

State Of Tennessee, Treasury Department

$27.8 Billion
Q3 2024

A detailed history of State Of Tennessee, Treasury Department transactions in Biogen Inc. stock. As of the latest transaction made, State Of Tennessee, Treasury Department holds 19,329 shares of BIIB stock, worth $2.75 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

19,329

Previous 61,199 68.42%

Holding current value

$2.75 Million

Previous $14.2 Million 73.6%

% of portfolio

0.01%

Previous 0.05%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$189.07 - $236.8 $7.92 Million - $9.91 Million	-41,870 Reduced 68.42%	19,329 $3.75 Million
Q2 2024 Aug 13, 2024	BUY	$190.52 - $236.72 $3.97 Million - $4.93 Million	20,831 Added 51.6%	61,199 $14.2 Million
Q1 2024 May 14, 2024	SELL	$212.02 - $267.71 $4.88 Million - $6.16 Million	-23,028 Reduced 36.32%	40,368 $8.7 Million
Q4 2023 Feb 14, 2024	BUY	$222.59 - $267.94 $5.71 Million - $6.87 Million	25,639 Added 67.91%	63,396 $16.4 Million
Q2 2023 Aug 15, 2023	SELL	$275.25 - $318.06 $1.48 Million - $1.71 Million	-5,391 Reduced 12.49%	37,757 $10.8 Million
Q1 2023 May 12, 2023	BUY	$256.56 - $292.34 $1.79 Million - $2.04 Million	6,964 Added 19.25%	43,148 $12 Million
Q4 2022 Feb 15, 2023	SELL	$252.44 - $306.72 $443,789 - $539,213	-1,758 Reduced 4.63%	36,184 $10 Million
Q2 2022 Aug 15, 2022	BUY	$187.54 - $223.02 $2.56 Million - $3.05 Million	13,662 Added 56.27%	37,942 $7.74 Million
Q1 2022 May 11, 2022	SELL	$193.77 - $244.14 $149,977 - $188,964	-774 Reduced 3.09%	24,280 $5.11 Million
Q4 2021 Feb 15, 2022	SELL	$223.92 - $287.77 $20.5 Million - $26.4 Million	-91,685 Reduced 78.54%	25,054 $6.01 Million
Q3 2021 Nov 12, 2021	BUY	$282.99 - $369.05 $25.4 Million - $33.2 Million	89,922 Added 335.32%	116,739 $33 Million
Q2 2021 Aug 11, 2021	SELL	$259.0 - $414.71 $70,189 - $112,386	-271 Reduced 1.0%	26,817 $9.29 Million
Q1 2021 May 10, 2021	SELL	$242.95 - $284.63 $128,520 - $150,569	-529 Reduced 1.92%	27,088 $7.58 Million
Q4 2020 Feb 09, 2021	SELL	$236.26 - $355.63 $1.03 Million - $1.55 Million	-4,351 Reduced 13.61%	27,617 $6.76 Million
Q3 2020 Nov 16, 2020	SELL	$264.77 - $305.71 $419,660 - $484,550	-1,585 Reduced 4.72%	31,968 $9.07 Million
Q2 2020 Aug 13, 2020	SELL	$258.66 - $342.55 $6.27 Million - $8.31 Million	-24,245 Reduced 41.95%	33,553 $8.98 Million
Q1 2020 May 15, 2020	SELL	$268.85 - $341.04 $2.36 Million - $2.99 Million	-8,764 Reduced 13.17%	57,798 $18.3 Million
Q4 2019 Feb 06, 2020	BUY	$220.06 - $304.07 $4.57 Million - $6.32 Million	20,786 Added 45.41%	66,562 $19.8 Million
Q3 2019 Oct 30, 2019	SELL	$217.44 - $243.88 $2.95 Million - $3.3 Million	-13,545 Reduced 22.83%	45,776 $10.7 Million
Q2 2019 Aug 12, 2019	SELL	$219.29 - $241.72 $1.9 Million - $2.09 Million	-8,665 Reduced 12.75%	59,321 $13.9 Million
Q1 2019 May 13, 2019	SELL	$216.71 - $338.96 $648,179 - $1.01 Million	-2,991 Reduced 4.21%	67,986 $16.1 Million
Q4 2018 Feb 11, 2019	SELL	$278.5 - $352.75 $401,875 - $509,018	-1,443 Reduced 1.99%	70,977 $21.4 Million
Q3 2018 Nov 13, 2018	SELL	$293.51 - $383.83 $3.32 Million - $4.34 Million	-11,299 Reduced 13.5%	72,420 $25.6 Million
Q2 2018 Aug 14, 2018	SELL	$257.52 - $306.91 $2.49 Million - $2.97 Million	-9,669 Reduced 10.35%	83,719 $24.3 Million
Q1 2018 May 11, 2018	SELL	$260.13 - $367.91 $16 Million - $22.6 Million	-61,376 Reduced 39.66%	93,388 $25.6 Million
Q4 2017 Feb 12, 2018	BUY	$307.64 - $344.58 $1.84 Million - $2.06 Million	5,986 Added 4.02%	154,764 $49.3 Million
Q3 2017 Nov 01, 2017	BUY	$281.15 - $329.69 $41.8 Million - $49.1 Million	148,778	148,778 $46.6 Million

Others Institutions Holding BIIB

# of Institutions

993

Shares Held

131M

Call Options Held

1.12M

Put Options Held

1.43M

View Full List

About BIOGEN INC.

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $20.5B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

More about BIIB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of State Of Tennessee, Treasury Department, based on Form 13F filings with the SEC.

News

Stay updated on State Of Tennessee, Treasury Department with notifications on news.

Account

State Of Tennessee, Treasury Department Biogen Inc. Transaction History